CDXC
Price:
$7.87
Market Cap:
$508.76M
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingred...[Read more]
Industry
Biotechnology
IPO Date
2008-06-25
Stock Exchange
NASDAQ
Ticker
CDXC
According to ChromaDex Corporation’s latest financial reports and current stock price. The company's current ROE is 35.46%. This represents a change of 296.07% compared to the average of 8.95% of the last 4 quarters.
The mean historical ROE of ChromaDex Corporation over the last ten years is -64.62%. The current 35.46% ROE has changed -154.87% with respect to the historical average. Over the past ten years (40 quarters), CDXC's ROE was at its highest in in the December 2024 quarter at 15.57%. The ROE was at its lowest in in the June 2019 quarter at -51.21%.
Average
-64.62%
Median
-55.11%
Minimum
-157.24%
Maximum
18.55%
Discovering the peaks and valleys of ChromaDex Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 480.00%
Maximum Annual ROE = 18.55%
Minimum Annual Increase = -206.89%
Minimum Annual ROE = -157.24%
| Year | ROE | Change |
|---|---|---|
| 2024 | 18.55% | -206.89% |
| 2023 | -17.35% | -69.92% |
| 2022 | -57.69% | -32.53% |
| 2021 | -85.50% | -29.52% |
| 2020 | -121.32% | -22.84% |
| 2019 | -157.24% | 28.27% |
| 2018 | -122.58% | 480.00% |
| 2017 | -21.14% | -28.01% |
| 2016 | -29.36% | -44.12% |
| 2015 | -52.54% | -61.02% |
The current ROE of ChromaDex Corporation (CDXC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-18.83%
5-year avg
-52.66%
10-year avg
-64.62%
ChromaDex Corporation’s ROE is greater than Exscientia plc (-32.05%), greater than Regulus Therapeutics Inc. (-57.53%), greater than Sage Therapeutics, Inc. (-67.10%), greater than Invivyd, Inc. (-92.97%), greater than Ikena Oncology, Inc. (-24.88%), greater than ARS Pharmaceuticals, Inc. (-38.77%), greater than Sinovac Biotech Ltd. (-1.13%), greater than Icosavax, Inc. (-35.64%), less than BioDelivery Sciences International, Inc. (57.33%), greater than iTeos Therapeutics, Inc. (-35.52%),
| Company | ROE | Market cap |
|---|---|---|
| -32.05% | $633.18M | |
| -57.53% | $564.95M | |
| -67.10% | $544.94M | |
| -92.97% | $294.00M | |
| -24.88% | $718.82M | |
| -38.77% | $1.04B | |
| -1.13% | $464.94M | |
| -35.64% | $769.04M | |
| 57.33% | $577.05M | |
| -35.52% | $448.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChromaDex Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ChromaDex Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ChromaDex Corporation's ROE?
How is the ROE calculated for ChromaDex Corporation (CDXC)?
What is the highest ROE for ChromaDex Corporation (CDXC)?
What is the 3-year average ROE for ChromaDex Corporation (CDXC)?
What is the 5-year average ROE for ChromaDex Corporation (CDXC)?
How does the current ROE for ChromaDex Corporation (CDXC) compare to its historical average?